ARI Apollo Commercial Real Estate Finance Liquidating Trust
Real Estate Investment Trusts · NYSE · SEC CIK 1467760 · Fiscal year ends 12/31
Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY-14.7%
TTM net income YoY3,267.7%
TTM EPS YoY633.3%
Revenue 3-yr CAGR-11.5%
Net income 3-yr CAGR-3.0%
Margins
Gross margin—
Operating margin—
Net margin55.5%
FCF margin—
EBITDA margin—
Returns
ROE8.5%
ROA2.2%
ROIC (approx.)—
Asset turnover0.04x
Leverage & solvency
Liabilities / assets41.3%
Debt / equity0.00x
Current ratio—
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.66x
Accruals ratio0.8%
Payout ratio106.8%
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $271.59M | $303.67M | $344.59M | $303.64M | $284.51M |
| SG&A expense | $27.41M | $29.65M | $29.52M | $29.66M | $28.84M |
| Interest expense | — | — | $466.11M | $270.52M | $162.52M |
| Pretax income | $127.05M | -$119.24M | $58.57M | $265.23M | $223.51M |
| Income tax | $331,000 | $394,000 | $442,000 | $0 | $0 |
| Net income | $126.72M | -$119.64M | $58.13M | $265.23M | $223.51M |
| EPS (basic) | 0.81 | -0.97 | 0.29 | 1.77 | 1.48 |
| EPS (diluted) | 0.81 | -0.97 | 0.29 | 1.68 | 1.46 |
| Dividends declared per share | 1.00 | 1.20 | 1.40 | 1.40 | 1.40 |
| Weighted avg. shares (diluted) | 138.87M | 139.67M | 141.28M | 165.50M | 168.40M |
| Banking | |||||
| Net interest income | $166.69M | $198.98M | $252.17M | $241.58M | $265.59M |
| Loans, net | $312.70M | $486.80M | $693.70M | — | — |
| Balance sheet | |||||
| Cash & equivalents | $139.82M | $317.40M | $225.44M | $222.03M | $343.11M |
| Total assets | $9.90B | $8.41B | $9.30B | $9.57B | $8.42B |
| Total liabilities | $8.04B | $6.54B | $7.09B | $7.21B | $6.12B |
| Shareholders' equity | $1.86B | $1.87B | $2.21B | $2.35B | $2.29B |
| Shares outstanding | 138.94M | 138.17M | 141.36M | 140.60M | 139.89M |
| Cash flow statement | |||||
| Operating cash flow | $142.52M | $200.26M | $273.86M | $267.70M | $199.38M |
| Investing cash flow | -$1.39B | $577.17M | $68.42M | -$1.34B | -$1.36B |
| Financing cash flow | $1.06B | -$689.31M | -$343.36M | $957.97M | $1.18B |
| Depreciation & amortization | $11.17M | $11.67M | $8.25M | $704,000 | $2.65M |
| Stock-based compensation | $13.63M | $16.47M | $17.44M | $18.25M | $17.63M |
| Dividends paid | $141.28M | $185.95M | $202.02M | $200.57M | $199.65M |
| Share buybacks | $0 | $40.81M | $0 | $0 | $0 |
Free plan shows the latest 5 periods; Pro shows all 16 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.